Deutsche Bank
LYEL icon

Deutsche Bank’s Lyell Immunopharma LYEL Stock Holding History

Deutsche Bank’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$129K Buy
+9,188
New +$166K ﹤0.01% 3416
2025
Q2 		– Sell
-4,122
Closed -$44.5K – 3675
2025
Q1 		$44.5K Hold
4,122
– – ﹤0.01% 3396
2024
Q4 		$52.8K Hold
4,122
– – ﹤0.01% 3406
2024
Q3 		$114K Buy
4,122
+1,206
+41% +$35.4K ﹤0.01% 3175
2024
Q2 		$84.6K Sell
2,916
-710
-20% -$33.8K ﹤0.01% 3170
2024
Q1 		$162K Buy
3,626
+126
+4% +$5.39K ﹤0.01% 2946
2023
Q4 		$136K Sell
3,500
-116
-3% -$4.18K ﹤0.01% 3080
2023
Q3 		$106K Buy
3,616
+605
+20% +$28.7K ﹤0.01% 3133
2023
Q2 		$192K Sell
3,011
-2,287
-43% -$127K ﹤0.01% 2901
2023
Q1 		$250K Buy
5,298
+1,552
+41% +$83K ﹤0.01% 2901
2022
Q4 		$260K Buy
3,746
+57
+2% +$5.66K ﹤0.01% 2812
2022
Q3 		$541K Sell
3,689
-401
-10% -$54.3K ﹤0.01% 2325
2022
Q2 		$533K Buy
4,090
+45
+1% +$4.6K ﹤0.01% 2553
2022
Q1 		$409K Buy
4,045
+3,328
+464% +$403K ﹤0.01% 2869
2021
Q4 		$111K Buy
717
+37
+5% +$8.25K ﹤0.01% 3662
2021
Q3 		$201K Buy
+680
New +$204K ﹤0.01% 3567

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Deutsche Bank's LYEL Position: Q2 2026 in Review

Deutsche Bank opened a new position in Lyell Immunopharma (LYEL) in Q2 2026: 9,188 shares worth $129K. The stake represents ﹤0.01% of the portfolio and ranks #3416 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in LYEL as recently as Q1 2025.

Deutsche Bank first reported a position in LYEL in Q3 2021 and has held it in 16 quarters since. The position peaked at $541K in Q3 2022. 87 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

  • Deutsche Bank held 9,188 shares of Lyell Immunopharma worth $129K as of Q2 2026.
  • Lyell Immunopharma was a new Deutsche Bank position in Q2 2026.
  • Lyell Immunopharma made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3416 holding.
  • Deutsche Bank first reported a position in Lyell Immunopharma in Q3 2021 and has held it in 16 quarters since.
  • Deutsche Bank's Lyell Immunopharma position peaked at $541K in Q3 2022.
  • 87 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.